Not all patients with premenopausal breast cancer will experience the negative effects of tamoxifen treatment on their bone mineral density

被引：0
|
作者：
Altundag, Kadri [1 ]
机构：
[1] Tepe Prime, MKA Breast Canc Clin, TR-06800 Cankaya, Ankara, Turkiye
来源：
BREAST CANCER | 2024年 / 31卷 / 05期
关键词：
D O I：
10.1007/s12282-024-01595-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：997 / 997
页数：1
相关论文
共 50 条
  • [21] Anthropometry, bone mineral density and risk of breast cancer in premenopausal and postmenopausal Saudi women
    AlFaris, Nora
    AlKehayez, Nora
    AlMushawah, Fatema
    AlNaeem, AbdulRhman
    AlAmri, Nadia
    AlMudawah, Ebtisam
    ARCHIVES OF MEDICAL SCIENCE, 2023, 19 (03) : 608 - 617
  • [22] BONE-MINERAL DENSITY AFTER ADJUVANT CHEMOTHERAPY FOR PREMENOPAUSAL BREAST-CANCER
    BRUNING, PF
    PIT, MJ
    DEJONGBAKKER, M
    VANDENENDE, A
    HART, A
    VANENK, A
    BRITISH JOURNAL OF CANCER, 1990, 61 (02) : 308 - 310
  • [23] Bone mineral density in early breast cancer patients
    Spanik, S.
    Spanikova, B.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2010, 111 (01): : 27 - 32
  • [24] Effects of tamoxifen on cognitive functions in premenopausal patients with breast cancer: A crosssectional study
    Ferencz, V.
    Toth-Faber, E.
    Nemeth, D.
    Landherr, L.
    Toth, M.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1201 - S1201
  • [25] Effects of oral clodronate on bone mineral density in patients with relapsing breast cancer
    Rizzoli, R
    Forni, M
    Schaad, MA
    Slosman, DO
    Sappino, AP
    Garcia, J
    Bonjour, JP
    BONE, 1996, 18 (06) : 531 - 537
  • [26] BONE MINERAL DENSITY IN PREMENOPAUSAL MALAYSIAN SLE PATIENTS
    Yeap, S. S.
    Fauzi, A. R.
    Kong, Norella C. T.
    Halim, A. G.
    Soehardy, Z.
    Rahimah, I
    Chew, S. H.
    Chow, S. K.
    Goh, E. M. L.
    NEPHROLOGY, 2005, 10 : A52 - A52
  • [27] Influence of zoledronic acid on bone mineral density in premenopausal women with hormone receptor positive or negative breast cancer and neoadjuvant or adjuvant chemotherapy or endocrine treatment
    Hadji, P.
    Kauka, A.
    Kalder, M.
    Bauer, T.
    Albert, U.
    Muth, M.
    Ziller, M.
    EJC SUPPLEMENTS, 2010, 8 (03): : 62 - 62
  • [28] Influence of zoledronic acid on bone mineral density in premenopausal women with hormone receptor positive or negative breast cancer and neoadjuvant or adjuvant chemotherapy or endocrine treatment
    Ziller, M.
    Hadji, P.
    Kauka, K.
    Bauer, T.
    Albert, U. S.
    Muth, M.
    Kalder, M.
    EJC SUPPLEMENTS, 2009, 7 (02): : 277 - 277
  • [29] Bone Mineral Density Following Surgical Oophorectomy and Tamoxifen Adjuvant Therapy for Breast Cancer
    Love, Richard R.
    Young, Gregory S.
    Laudico, Adriano V.
    Nguyen Van Dinh
    Uy, Gemma B.
    Le Hong Quang
    De La Pena, Arturo S.
    Dofitas, Rodney B.
    Bisquera, Orlino C., Jr.
    Siguan, Stephen S. S.
    Salvador, Jonathan D. S.
    Rica Mirasol-Lumague, Maria
    Navarro, Narciso S., Jr.
    Nguyen Dieu Linh
    Jarjoura, David
    CANCER, 2013, 119 (21) : 3746 - 3752
  • [30] Effects of Aromatase inhibitors on bone mineral density and trabecular bone score in patients with breast cancer
    Dabbagh, V.
    Shandiz, F. Homaee
    Kermani, A. Taghizadeh
    Javan, F. Nesari
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S465 - S465
12345